共 50 条
- [6] Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma Head and Neck Pathology, 2022, 16 : 453 - 465
- [8] Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma HEAD & NECK PATHOLOGY, 2022, 16 (02): : 453 - 465